- Home
- GNFT vs EGHT Comparison
GNFT vs EGHT Comparison
Compare GNFT & EGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- EGHT
- Stock Information
- Founded
- GNFT 1999
- EGHT 1987
- Country
- GNFT France
- EGHT United States
- Employees
- GNFT N/A
- EGHT N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- EGHT EDP Services
- Sector
- GNFT Health Care
- EGHT Technology
- Exchange
- GNFT Nasdaq
- EGHT Nasdaq
- Market Cap
- GNFT 249.0M
- EGHT 250.2M
- IPO Year
- GNFT 2019
- EGHT 1997
- Fundamental
- Price
- GNFT $5.35
- EGHT $2.01
- Analyst Decision
- GNFT Strong Buy
- EGHT Buy
- Analyst Count
- GNFT 1
- EGHT 6
- Target Price
- GNFT $13.00
- EGHT $2.83
- AVG Volume (30 Days)
- GNFT 20.3K
- EGHT 832.3K
- Earning Date
- GNFT 09-19-2024
- EGHT 10-30-2024
- Dividend Yield
- GNFT N/A
- EGHT N/A
- EPS Growth
- GNFT N/A
- EGHT N/A
- EPS
- GNFT 0.47
- EGHT N/A
- Revenue
- GNFT $86,225,222.00
- EGHT $723,565,000.00
- Revenue This Year
- GNFT $155.44
- EGHT $0.85
- Revenue Next Year
- GNFT N/A
- EGHT $2.15
- P/E Ratio
- GNFT $11.10
- EGHT N/A
- Revenue Growth
- GNFT 175.45
- EGHT N/A
- 52 Week Low
- GNFT $2.89
- EGHT $1.51
- 52 Week High
- GNFT $6.05
- EGHT $3.92
- Technical
- Relative Strength Index (RSI)
- GNFT 60.10
- EGHT 54.65
- Support Level
- GNFT $5.06
- EGHT $1.89
- Resistance Level
- GNFT $6.05
- EGHT $2.08
- Average True Range (ATR)
- GNFT 0.31
- EGHT 0.09
- MACD
- GNFT 0.06
- EGHT 0.03
- Stochastic Oscillator
- GNFT 65.85
- EGHT 78.13
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About EGHT 8x8 Inc
8x8 Inc provides contact-center-as-a-service and unified-communications-as-a-service software applications to approximately 2.5 million users. The company's unified platform enables omnichannel communication to assist employees in communicating across voice, video, text, chat, and contact centers. The Company also generates revenue from sales of hardware and professional services, which are complementary to the delivery of its integrated technology platform.. Geographically, it derives a majority of revenue from the United States.